Key result
STEMI and NSTEMI show no difference in monocyte-to-HDL ratio.
Why the study?
This study sought to compare patients with STEMI and NSTEMI in terms of the monocyte-to-HDL cholesterol ratio.
Does the monocyte-to-HDL cholesterol ratio differ between patients with STEMI and NSTEMI?
Cohort (n=109)
No
Does the monocyte-to-HDL cholesterol ratio differ between patients with STEMI and NSTEMI?
The monocyte-to-HDL cholesterol ratio does not significantly differ between patients presenting with STEMI versus NSTEMI.
Answers are grounded in this paper and cite their sources.
MHR did not differ between STEMI and NSTEMI; leaves open its comparative prognostic utility and requires prospective validation before clinical consideration.
Introduction This study sought to compare patients with ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in terms of the monocyte-to-HDL cholesterol ratio. Materials and Methods A total of 79 patients with non-ST-segment elevation myocardial infarction and 30 patients with 30 ST-segment elevation myocardial infarction were included in the study. Demographics, comorbidities, smoking status, medical history, and initial laboratory findings were retrospectively noted from the hospital computer-based patient data system. Results Significant differences were detected between the ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction groups in relation to the neutrophil count [7.27 (6.05-9.05) versus 5.41 (4.26-7.21), p<0.001] and mean platelet volume [9.4 (8.8-10) versus 8.6 (7.3-9.5), p=0.002]. There was no statistically significant difference between the two groups in the term of the monocyte-to-HDL cholesterol ratio [0.016 (0.012-0.021) versus 0.016 (0.011-0.024), p=0.757, Bonferroni-corrected p value: 0.0033)]. Conclusion Based on the results of our study, the monocyte-to-HDL cholesterol ratio did not significantly differ between the patients with ST-segment elevation myocardial infarction and those with non-ST-segment elevation myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Özdemir et al. (2021) conducted a cohort in Acute coronary syndrome (STEMI and NSTEMI) (n=109). ST-segment elevation myocardial infarction (STEMI) vs. Non-ST-segment elevation myocardial infarction (NSTEMI) was evaluated on Monocyte-to-HDL cholesterol ratio (MHR) (p=0.757). The monocyte-to-HDL cholesterol ratio did not differ between patients with STEMI and NSTEMI.
Synapse has enriched 10 related papers. Consider them for comparative context: